DR. BRUCE M STARK M.D. NPI 1902801301

NPI Details

DR. Bruce M Stark, M.D. is an internal medicine in Burbank, CA with 36 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Bruce M Stark, M.D. NPI is 1902801301. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UN OF CALIFORNIA, IRVINE, COLLEGE OF MEDICINE
Graduation Year:1990

The provider's business location address is:

201 S BUENA VISTA ST
SUITE 300
BURBANK, CA
ZIP 91505-569
Phone: (818) 842-7145
Fax: (818) 842-8202

The NPI 1902801301 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Liver function blood test panel (HCPCS:80076)
• Folic acid level, serum (HCPCS:82746)
• Hemoglobin a1c level (HCPCS:83036)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Vitamin d-3 level (HCPCS:82306)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Rheumatoid factor analysis (HCPCS:86430)
• Uric acid level, blood (HCPCS:84550)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Testosterone (hormone) level, total (HCPCS:84403)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• X-ray of chest, 1 view (HCPCS:71045)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• X-ray of chest, 2 views (HCPCS:71046)
• Measurement of total estradiol (hormone) (HCPCS:82670)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)

The enumeration date for this NPI number is 6/14/2005 and was last updated on 8/29/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.